Herpesvirus Vaccine Research Review on Glycoprotein B Antigens

A review document authored by Solomon English, last updated on May 29, 2026, and shared under a CC-BY-4.0 license. The 60.2 KB document discusses the progress and prospects of using glycoprotein B (gB) antigens for vaccines against herpesviruses like EBV, HCMV, and HSV. It covers structural biology, in vitro studies, and results from previous in vivo vaccine trials.

Use Cases

• Literature review on herpesvirus vaccine development based on the described focus on gB antigens.
• Analysis of glycoprotein structure-function relationships for vaccine design based on the discussion of pre-fusion conformation stabilization.
• Comparative assessment of vaccine antigen candidates based on the review of gB versus alternative glycoproteins like EBV gH/gL and HCMV pentamer.

Strengths

• Document is under an open CC-BY-4.0 license, facilitating reuse.
• Specific focus on glycoprotein B antigens for multiple herpesviruses is detailed in the description.
• Author and precise last update timestamp (2026-05-29 06:07:35) are provided.

Limitations

• The dataset is a 60.2 KB document, indicating a very limited scope of information.
• Row count and column-level documentation are absent; data structure must be inferred after download.
• Description metadata is limited; actual data quality requires manual inspection after download.

Provenance

Source

figshare, authored by Solomon English.

Collection Method

Likely a literature review and synthesis authored for academic purposes.

Freshness

Last updated 2026-05-29 06:07:35; freshness should be verified.